Table 1 Inhibition of pathobiont growth on agar next to probiotic candidates.

From: Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms

 

Inhibition ratio

A. actinomycetemcomitans

P. intermedia

P. gingivalis

F. nucleatum

L. rhamnosus GG

0,352 ± 0,049

0,034 ± 0,040

0,672 ± 0,071

0,291 ± 0,077

L. pentosus KCA1

0,486 ± 0,081

0,319 ± 0,092

0,631 ± 0,058

0,244 ± 0,114

L. plantarum WCFS1

0,198 ± 0,110

0,368 ± 0,045

0,931 ± 0,089

0,401 ± 0,069

L. reuteri V038

0,000 ± 0,000

0,000 ± 0,000

0,000 ± 0,000

0,000 ± 0,000

L. fermentum V001

0,000 ± 0,000

0,000 ± 0,000

0,000 ± 0,000

0,000 ± 0,000

L. reuteri F471

0,337 ± 0,027

0,000 ± 0,000

0,716 ± 0,242

0,000 ± 0,000

S. salivarius AMBR074

0,413 ± 0,064

0,190 ± 0,043

0,716 ± 0,249

0,209 ± 0,080

S. salivarius AMBR075

0,415 ± 0,090

0,220 ± 0,063

0,750 ± 0,229

0,231 ± 0,032

S. salivarius AMBR024

0,410 ± 0,074

0,184 ± 0,066

0,674 ± 0,229

0,185 ± 0,069

S. salivarius AMBR158

0,467 ± 0,085

0,000 ± 0,000

0,822 ± 0,171

0,235 ± 0,056

  1. Data are expressed as the inhibition ratio (± standard deviation) between the edge of the probiotic’s spot and the pathobiont’s spot, relative to the diameter of the pathobiont’s control spot (Supplementary Fig. 1). Bold values represent statistically significant differences (ANOVA with Tukey HSD; p < 0.05) from the control spot (n = 9).